Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Administration of donor specific T-cells transduced ex vivo using a retroviral vector coding for a leukemia-specific TCR, as a cellular treatment after allogeneic stem cell transplantation for patients with refractory or relapsed hematological malignancies.

Proposed period of release:
01/03/2012 to 31/12/2017

Name of the Institute(s) or Company(ies)
Leiden University Medical Center, Albinusdreef 2
2333 ZA Leiden
PO Box 9600
2300 RC Leiden
The Netherlands;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
RNA Virus

Identity of the GMO:
Retrovirus, Moloney murine leukemia virus (Mo-MuLV)

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
Mo-MuLVGamma retrovirusMurine leukemia virusdl58rev mutant

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known